Answer
Yes, bosutinib is indicated for adults with newly diagnosed chronic-phase Philadelphia chromosome-positive chronic myelogenous leukaemia.
Sources for this answer
- Bosutinib 100 mg film-coated tabletsDr. Reddy's Laboratories (UK) Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 2Document updated
Sources checked